Harrington Investments, Inc Gilead Sciences, Inc. Transaction History

Harrington Investments, Inc

$173 Million
Q1 2025

A detailed history of Harrington Investments, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Harrington Investments, Inc holds 20,043 shares of GILD stock, worth $2.01 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares

20,043

Previous 19,802 1.22%

Holding current value

$2.01 Million

Previous $1.83 Million 22.74%

% of portfolio

1.29%

Previous 1.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 11, 2025	BUY	$89.14 - $117.41 $21,482 - $28,295	241 Added 1.22%	20,043 $2.25 Million
Q4 2024 Feb 10, 2025	SELL	$83.95 - $97.9 $132,221 - $154,192	-1,575 Reduced 7.37%	19,802 $1.83 Million
Q3 2024 Oct 11, 2024	SELL	$66.59 - $83.99 $35,292 - $44,514	-530 Reduced 2.42%	21,377 $1.79 Million
Q2 2024 Aug 06, 2024	BUY	$63.15 - $72.88 $2,526 - $2,915	40 Added 0.18%	21,907 $1.5 Million
Q1 2024 Apr 26, 2024	BUY	$71.58 - $87.29 $73,083 - $89,123	1,021 Added 4.9%	21,867 $1.6 Million
Q4 2023 Jan 17, 2024	BUY	$73.27 - $83.09 $4,396 - $4,985	60 Added 0.29%	20,846 $1.69 Million
Q3 2023 Oct 19, 2023	BUY	$73.94 - $80.67 $33,273 - $36,301	450 Added 2.21%	20,786 $1.56 Million
Q2 2023 Jul 20, 2023	BUY	$76.01 - $86.7 $6,080 - $6,936	80 Added 0.39%	20,336 $1.57 Million
Q1 2023 Apr 28, 2023	BUY	$77.31 - $88.08 $88,906 - $101,292	1,150 Added 6.02%	20,256 $1.68 Million
Q4 2022 Jan 11, 2023	SELL	$62.32 - $89.47 $28,044 - $40,261	-450 Reduced 2.3%	19,106 $0
Q3 2022 Oct 19, 2022	BUY	$59.54 - $68.01 $38,701 - $44,206	650 Added 3.44%	19,556 $1.21 Million
Q2 2022 Jul 22, 2022	SELL	$57.72 - $65.01 $77,575 - $87,373	-1,344 Reduced 6.64%	18,906 $1.17 Million
Q1 2022 Apr 26, 2022	BUY	$57.92 - $72.58 $4,923 - $6,169	85 Added 0.42%	20,250 $1.2 Million
Q4 2021 Jan 21, 2022	BUY	$64.88 - $73.64 $1,557 - $1,767	24 Added 0.12%	20,165 $1.46 Million
Q3 2021 Oct 28, 2021	SELL	$67.69 - $73.03 $8,461 - $9,128	-125 Reduced 0.62%	20,141 $1.41 Million
Q2 2021 Aug 03, 2021	BUY	$63.47 - $69.35 $13,074 - $14,286	206 Added 1.03%	20,266 $1.4 Million
Q1 2021 Apr 30, 2021	BUY	$60.0 - $68.46 $5,880 - $6,709	98 Added 0.49%	20,060 $1.3 Million
Q4 2020 Jan 13, 2021	SELL	$56.65 - $64.55 $89,903 - $102,440	-1,587 Reduced 7.36%	19,962 $1.16 Million
Q3 2020 Oct 21, 2020	SELL	$62.1 - $78.08 $197,788 - $248,684	-3,185 Reduced 12.88%	21,549 $1.36 Million
Q2 2020 Jul 21, 2020	BUY	$72.34 - $84.0 $268,743 - $312,060	3,715 Added 17.67%	24,734 $1.9 Million
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $24,989 - $32,007	-399 Reduced 1.86%	21,019 $1.57 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $30,686 - $33,754	-498 Reduced 2.27%	21,418 $1.39 Million
Q3 2019 Nov 05, 2019	SELL	$62.51 - $69.0 $18,815 - $20,769	-301 Reduced 1.35%	21,916 $1.39 Million
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $13,673 - $15,332	-221 Reduced 0.98%	22,217 $1.5 Million
Q1 2019 Apr 29, 2019	SELL	$62.53 - $70.05 $51,587 - $57,791	-825 Reduced 3.55%	22,438 $1.46 Million
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $47,826 - $62,410	-790 Reduced 3.28%	23,263 $1.46 Million
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $35,283 - $39,065	-495 Reduced 2.02%	24,053 $1.86 Million
Q2 2018 Oct 19, 2018	SELL	$64.88 - $75.68 $8,758 - $10,216	-135 Reduced 0.55%	24,548 $1.74 Million
Q1 2018 Apr 12, 2018	BUY	$72.84 - $88.8 $26,440 - $32,234	363 Added 1.49%	24,683 $1.86 Million
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $109,286 - $128,286	1,536 Added 6.74%	24,320 $1.74 Million
Q3 2017 Oct 23, 2017	BUY	$72.11 - $85.47 $1.64 Million - $1.95 Million	22,784	22,784 $1.85 Million

Others Institutions Holding GILD

# of Institutions

2,272

Shares Held

996M

Call Options Held

9.63M

Put Options Held

9.92M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $126B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harrington Investments, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harrington Investments, Inc with notifications on news.

Account

Harrington Investments, Inc Gilead Sciences, Inc. Transaction History